pirtobrutinib,venetoclax,rituximab
roche,eli lilly,abbvie
['pirto', 'bruin', 'lymsm', 'cml']
congress|#17icml| , university of western australia reports updated results from the bruin study evaluating pirtobrutinib in pts with cbtki pretreated r/r mcl. it demonstrated durable efficacy &amp; well tolerated. responses were observed in pts with hr disease #lymsm 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm